| Silicone and Scleroderma Revisited |
|
|
|
| Thursday, 03 May 2012 22:39 |
|
Silicone, a synthetic polymer considered to be a biologically inert substance, is used in a multitude of medical products, the most publicly recognized of which are breast implants. Silicone breast implants have been in use since the early 1960s for cosmetic and reconstructive purposes, and reports of autoimmune disease-like syndromes began appearing in the medical literature soon thereafter. Over the previous year, silicone implants have been suggested as playing a role in a new syndrome that encompasses a wide array of immune-related manifestations, termed ASIA (‘Autoimmune Syndrome Induced by Adjuvant’).
Scleroderma, a relatively rare connective tissue disease with skin manifestations and systemic effects, has also been described in association with silicone implantation and rupture. However, epidemiological studies and meta-analyses have failed to corroborate the clinical impression of silicone-induced scleroderma. The following review describes the mechanisms by which silicone may mediate autoimmunity in general, as well as the evidence for causal associations with more specific autoimmune syndromes in general, and scleroderma in particular. Continue reading the full review article, by downloading it from the link provided below. |
More articles :
» Platelet Gel In The Treatment Of Severe Scleroderma Skin Ulcers
Dilia Giuggioli, Michele Colaci, Andreina Manfredi, Mariateresa Mariano and Clodoveo FerriSystemic sclerosis (SSc) is characterized by microvascular damage and fibrosis of the skin and internal organs. Non-healing skin ulcers, mainly non-venous leg...
» Egr-1: A Target for Scleroderma Therapy
Two separate research groups funded by the (NIAMS) have discovered that the molecule EGR-1 (early growth response 1), which regulates gene expression, plays a central role in the development of fibrosis, a condition in which organ-supporting tissue...
» UTHealth Scientists Closing In On Genes Tied To Scleroderma
A new study designed to test suspected links between genes and two immune disorders could open the door to better ways to diagnose and treat the conditions that affect a combined total of approximately 2.5 million people in the United States, report...
» Imaging Lung Disease in Systemic Sclerosis
Diane Strollo & Jonathan GoldinPublished online: 16 March 2010Copyright, The Author(s) 2010. This article is published with open access at Springerlink.comAbstract Interstitial lung disease and pulmonary hypertension (PH) are the most common...
» Systemic Sclerosis (Scleroderma)
Panayiotis G. Vlachoyiannopoulos1November 2001Systemic sclerosis (SSc) is an autoimmune systemic disease characterized by small vessel involvement that leads to tissue ischemia and fibroblast stimulation resulting in accumulation of collagen...
» Actelion Announces FDA Approval of Brand Name, Veletri, for Pulmonary Arterial Hypertension
US, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved the brand name VELETRI® for the company's epoprostenol for injection therapy. VELETRI has been commercially available since April 2010 as Epoprostenol for...



Comments
There is "causation of b implants. I have lived it".
I note that the ASIA syndrome study on breast implants bundles disease with heavy metals attached, ALUMINUM. But scientific truth is the problem IS silicone, this man made adjuvant, ALL heavy metals in breast implant lot numbers, PLATINUM/ aluminum and genetics. Genetics is NOT the "cause".
Personally, I fully understand the need to "bundle disease"/what I term it to what reserachers did to make sense of breast implant disease w/ ASIA syndrome...but not just HLA-type patient, but do SNPs , total gene sequence of human patient. Don't say it COSTS TOO MUCH...LIFE and generations to come, OUR OFFSPRING are priceless!
Cindy
It is Cindy Fuchs-Morrissey
Just wanted to make this clear.
Thank you.
Cindy
RSS feed for comments to this post